Royalty Pharma plc Class A Ordinary Shares vs iShares Semiconductor ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.41 (market cap $25.27B), while iShares Semiconductor ETF trades at $559.71 (market cap $48.19B). The key difference: iShares Semiconductor ETF is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares Semiconductor ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and iShares Semiconductor ETF for 46 Days on average.
| RPRX | SOXX | |
|---|---|---|
Market Cap | $25.27B | $48.19B |
Volume | 3,671,183 | 10,257,578 |
Sector | Health | Sector/Thematic |
52-Week High | $63.96 | $655.01 |
52-Week Low | $35.44 | $268.10 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXX trades at $559.40, down 4.04% over the past 24 hours, with technical indicators showing a bullish moving average signal but neutral oscillators. The semiconductor ETF faces mixed sentiment with strong AI-driven earnings growth projections but concerns about valuation premiums. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.33 dividend payment in September 2026.
The outlook remains cautiously optimistic with AI infrastructure demand driving earnings growth, though high valuations and bearish bets from notable investors like Michael Burry present significant risks. Wall Street analysts maintain positive ratings based on semiconductor market expansion projections, with Bank of America forecasting near-doubling of the global chip market by 2030.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →